Blakey David C
AstraZeneca, Alderley Park, Macclesfield, Cheshire, SK10 4TF, UK.
Expert Opin Investig Drugs. 2003 Sep;12(9):1577-82. doi: 10.1517/13543784.12.9.1577.
The 5th Annual Anti-Cancer Drug Discovery and Development Summit brought together an international group of academic and industry scientists to discuss recent therapeutic developments in the field of oncology. The focus of the meeting was novel targeted approaches, i.e., those agents directed against targets that are overexpressed or overactive in tumour cells. It was acknowledged that cytotoxic agents will continue to play a key role in the treatment of cancer and new developments in this area were also discussed. With over 400 anticancer drugs in clinical development and a number of recent registrations, there is great optimism that significant therapeutic advances can be made.
第五届年度抗癌药物发现与开发峰会汇聚了一批国际学术和产业界科学家，共同探讨肿瘤学领域近期的治疗进展。会议重点是新型靶向方法，即针对肿瘤细胞中过度表达或过度活跃靶点的药物。大家认识到细胞毒性药物将继续在癌症治疗中发挥关键作用，同时也讨论了该领域的新进展。目前有400多种抗癌药物正在进行临床试验，并且近期有一些药物获批上市，人们对取得重大治疗进展充满了极大的乐观情绪。
